Startup-094
Düsseldorf, Germany
The key goal of CureDiab is the development of novel GABA-A receptor modulators as a first-in-class therapy of fatty liver disease.
Düsseldorf, Germany
The key goal of CureDiab is the development of novel GABA-A receptor modulators as a first-in-class therapy of fatty liver disease.
Cologne, Germany
The unique platform that combines Healthcare technologies with Orphan Disease treatments based on Cannabinoids.
Halle, Germany
ScobyTec’s platform technology is the solution for the future need for new materials like leather replacement, technical papers and lightweight construction materials, made with biofabrication and in a sustainable process throughout the entire production line.
Heidelberg, Germany
Companion Diagnostics for multiple cancer immunotherapies based on the immune checkpoint AHR using our proprietary Signature Technology
Bruchsal, Germany
We developed Small Molecules for the treatment of adenocarcinoma, lung tumor.
Runkel, Germany
B2B online Handelsplattform für Biotech und Pharma Unternehmen zum Handel von Drug Candidates, Formulares etc.